Report Detail

Request for Sample of this report

Service & Software Global Rare Disease CRO Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4571952
    • |
  • 18 December, 2023
    • |
  • Global
    • |
  • 151 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Rare Disease CRO Service market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Rare disease CRO (Contract Research Organization) service refers to the specialized research and clinical trial services tailored to address the unique needs of drug development for rare diseases. These services may include clinical trial design, patient recruitment, regulatory support, and data analysis specifically focused on rare disease therapeutics.
The Global Info Research report includes an overview of the development of the Rare Disease CRO Service industry chain, the market status of Cardiovascular (Drug Development Strategy, Clinical Trial Management), Neuroscience (Drug Development Strategy, Clinical Trial Management), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rare Disease CRO Service.
Regionally, the report analyzes the Rare Disease CRO Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rare Disease CRO Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rare Disease CRO Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rare Disease CRO Service industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Drug Development Strategy, Clinical Trial Management).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rare Disease CRO Service market.
Regional Analysis: The report involves examining the Rare Disease CRO Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rare Disease CRO Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rare Disease CRO Service:
Company Analysis: Report covers individual Rare Disease CRO Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rare Disease CRO Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiovascular, Neuroscience).
Technology Analysis: Report covers specific technologies relevant to Rare Disease CRO Service. It assesses the current state, advancements, and potential future developments in Rare Disease CRO Service areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rare Disease CRO Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rare Disease CRO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Drug Development Strategy
Clinical Trial Management
Market segment by Application
Cardiovascular
Neuroscience
Ophthalmology
Others
Market segment by players, this report covers
Precision for Medicine
Orphan-Reach
Medpace
Parexel
PPD
Worldwide Clinical Trials
AllStripes
LabCorp
Novotech
Syneos Health
Vial
Machaon Diagnostics
Caidya
Simbec Orion
Linical
MMS
Veristat
Celero
Rho
PROMETRIKA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Rare Disease CRO Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Rare Disease CRO Service, with revenue, gross margin and global market share of Rare Disease CRO Service from 2018 to 2023.
Chapter 3, the Rare Disease CRO Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Rare Disease CRO Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rare Disease CRO Service.
Chapter 13, to describe Rare Disease CRO Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Rare Disease CRO Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Rare Disease CRO Service by Type
    • 1.3.1 Overview: Global Rare Disease CRO Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Rare Disease CRO Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Drug Development Strategy
    • 1.3.4 Clinical Trial Management
  • 1.4 Global Rare Disease CRO Service Market by Application
    • 1.4.1 Overview: Global Rare Disease CRO Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Cardiovascular
    • 1.4.3 Neuroscience
    • 1.4.4 Ophthalmology
    • 1.4.5 Others
  • 1.5 Global Rare Disease CRO Service Market Size & Forecast
  • 1.6 Global Rare Disease CRO Service Market Size and Forecast by Region
    • 1.6.1 Global Rare Disease CRO Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Rare Disease CRO Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Rare Disease CRO Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Rare Disease CRO Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Rare Disease CRO Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Rare Disease CRO Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Rare Disease CRO Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Precision for Medicine
    • 2.1.1 Precision for Medicine Details
    • 2.1.2 Precision for Medicine Major Business
    • 2.1.3 Precision for Medicine Rare Disease CRO Service Product and Solutions
    • 2.1.4 Precision for Medicine Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Precision for Medicine Recent Developments and Future Plans
  • 2.2 Orphan-Reach
    • 2.2.1 Orphan-Reach Details
    • 2.2.2 Orphan-Reach Major Business
    • 2.2.3 Orphan-Reach Rare Disease CRO Service Product and Solutions
    • 2.2.4 Orphan-Reach Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Orphan-Reach Recent Developments and Future Plans
  • 2.3 Medpace
    • 2.3.1 Medpace Details
    • 2.3.2 Medpace Major Business
    • 2.3.3 Medpace Rare Disease CRO Service Product and Solutions
    • 2.3.4 Medpace Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Medpace Recent Developments and Future Plans
  • 2.4 Parexel
    • 2.4.1 Parexel Details
    • 2.4.2 Parexel Major Business
    • 2.4.3 Parexel Rare Disease CRO Service Product and Solutions
    • 2.4.4 Parexel Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Parexel Recent Developments and Future Plans
  • 2.5 PPD
    • 2.5.1 PPD Details
    • 2.5.2 PPD Major Business
    • 2.5.3 PPD Rare Disease CRO Service Product and Solutions
    • 2.5.4 PPD Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 PPD Recent Developments and Future Plans
  • 2.6 Worldwide Clinical Trials
    • 2.6.1 Worldwide Clinical Trials Details
    • 2.6.2 Worldwide Clinical Trials Major Business
    • 2.6.3 Worldwide Clinical Trials Rare Disease CRO Service Product and Solutions
    • 2.6.4 Worldwide Clinical Trials Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Worldwide Clinical Trials Recent Developments and Future Plans
  • 2.7 AllStripes
    • 2.7.1 AllStripes Details
    • 2.7.2 AllStripes Major Business
    • 2.7.3 AllStripes Rare Disease CRO Service Product and Solutions
    • 2.7.4 AllStripes Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 AllStripes Recent Developments and Future Plans
  • 2.8 LabCorp
    • 2.8.1 LabCorp Details
    • 2.8.2 LabCorp Major Business
    • 2.8.3 LabCorp Rare Disease CRO Service Product and Solutions
    • 2.8.4 LabCorp Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 LabCorp Recent Developments and Future Plans
  • 2.9 Novotech
    • 2.9.1 Novotech Details
    • 2.9.2 Novotech Major Business
    • 2.9.3 Novotech Rare Disease CRO Service Product and Solutions
    • 2.9.4 Novotech Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Novotech Recent Developments and Future Plans
  • 2.10 Syneos Health
    • 2.10.1 Syneos Health Details
    • 2.10.2 Syneos Health Major Business
    • 2.10.3 Syneos Health Rare Disease CRO Service Product and Solutions
    • 2.10.4 Syneos Health Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Syneos Health Recent Developments and Future Plans
  • 2.11 Vial
    • 2.11.1 Vial Details
    • 2.11.2 Vial Major Business
    • 2.11.3 Vial Rare Disease CRO Service Product and Solutions
    • 2.11.4 Vial Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Vial Recent Developments and Future Plans
  • 2.12 Machaon Diagnostics
    • 2.12.1 Machaon Diagnostics Details
    • 2.12.2 Machaon Diagnostics Major Business
    • 2.12.3 Machaon Diagnostics Rare Disease CRO Service Product and Solutions
    • 2.12.4 Machaon Diagnostics Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Machaon Diagnostics Recent Developments and Future Plans
  • 2.13 Caidya
    • 2.13.1 Caidya Details
    • 2.13.2 Caidya Major Business
    • 2.13.3 Caidya Rare Disease CRO Service Product and Solutions
    • 2.13.4 Caidya Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Caidya Recent Developments and Future Plans
  • 2.14 Simbec Orion
    • 2.14.1 Simbec Orion Details
    • 2.14.2 Simbec Orion Major Business
    • 2.14.3 Simbec Orion Rare Disease CRO Service Product and Solutions
    • 2.14.4 Simbec Orion Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Simbec Orion Recent Developments and Future Plans
  • 2.15 Linical
    • 2.15.1 Linical Details
    • 2.15.2 Linical Major Business
    • 2.15.3 Linical Rare Disease CRO Service Product and Solutions
    • 2.15.4 Linical Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Linical Recent Developments and Future Plans
  • 2.16 MMS
    • 2.16.1 MMS Details
    • 2.16.2 MMS Major Business
    • 2.16.3 MMS Rare Disease CRO Service Product and Solutions
    • 2.16.4 MMS Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 MMS Recent Developments and Future Plans
  • 2.17 Veristat
    • 2.17.1 Veristat Details
    • 2.17.2 Veristat Major Business
    • 2.17.3 Veristat Rare Disease CRO Service Product and Solutions
    • 2.17.4 Veristat Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Veristat Recent Developments and Future Plans
  • 2.18 Celero
    • 2.18.1 Celero Details
    • 2.18.2 Celero Major Business
    • 2.18.3 Celero Rare Disease CRO Service Product and Solutions
    • 2.18.4 Celero Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Celero Recent Developments and Future Plans
  • 2.19 Rho
    • 2.19.1 Rho Details
    • 2.19.2 Rho Major Business
    • 2.19.3 Rho Rare Disease CRO Service Product and Solutions
    • 2.19.4 Rho Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Rho Recent Developments and Future Plans
  • 2.20 PROMETRIKA
    • 2.20.1 PROMETRIKA Details
    • 2.20.2 PROMETRIKA Major Business
    • 2.20.3 PROMETRIKA Rare Disease CRO Service Product and Solutions
    • 2.20.4 PROMETRIKA Rare Disease CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 PROMETRIKA Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Rare Disease CRO Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Rare Disease CRO Service by Company Revenue
    • 3.2.2 Top 3 Rare Disease CRO Service Players Market Share in 2022
    • 3.2.3 Top 6 Rare Disease CRO Service Players Market Share in 2022
  • 3.3 Rare Disease CRO Service Market: Overall Company Footprint Analysis
    • 3.3.1 Rare Disease CRO Service Market: Region Footprint
    • 3.3.2 Rare Disease CRO Service Market: Company Product Type Footprint
    • 3.3.3 Rare Disease CRO Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Rare Disease CRO Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Rare Disease CRO Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Rare Disease CRO Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Rare Disease CRO Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Rare Disease CRO Service Consumption Value by Type (2018-2029)
  • 6.2 North America Rare Disease CRO Service Consumption Value by Application (2018-2029)
  • 6.3 North America Rare Disease CRO Service Market Size by Country
    • 6.3.1 North America Rare Disease CRO Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Rare Disease CRO Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Rare Disease CRO Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Rare Disease CRO Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Rare Disease CRO Service Market Size by Country
    • 7.3.1 Europe Rare Disease CRO Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Rare Disease CRO Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Rare Disease CRO Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Rare Disease CRO Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Rare Disease CRO Service Market Size by Region
    • 8.3.1 Asia-Pacific Rare Disease CRO Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Rare Disease CRO Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Rare Disease CRO Service Consumption Value by Type (2018-2029)
  • 9.2 South America Rare Disease CRO Service Consumption Value by Application (2018-2029)
  • 9.3 South America Rare Disease CRO Service Market Size by Country
    • 9.3.1 South America Rare Disease CRO Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Rare Disease CRO Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Rare Disease CRO Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Rare Disease CRO Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Rare Disease CRO Service Market Size by Country
    • 10.3.1 Middle East & Africa Rare Disease CRO Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Rare Disease CRO Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Rare Disease CRO Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Rare Disease CRO Service Market Drivers
  • 11.2 Rare Disease CRO Service Market Restraints
  • 11.3 Rare Disease CRO Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Rare Disease CRO Service Industry Chain
  • 12.2 Rare Disease CRO Service Upstream Analysis
  • 12.3 Rare Disease CRO Service Midstream Analysis
  • 12.4 Rare Disease CRO Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Rare Disease CRO Service. Industry analysis & Market Report on Rare Disease CRO Service is a syndicated market report, published as Global Rare Disease CRO Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Rare Disease CRO Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,742.24
    		4,113.36
    		5,484.48
    		3,201.60
    		4,802.40
    		6,403.20
    		541,557.60
    		812,336.40
    		1,083,115.20
    		290,162.40
    		435,243.60
    		580,324.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo